Healthcare -
Biotechnology - NASDAQ - US
$ 115.69
1.08 %
$ 11.1 B
Market Cap
75.12
P/E
SRPT - CASH & EQUIVALENTS
Cash & Equivalents SRPT - Sarepta Therapeutics, Inc.
428 M
LAST VALUE
-55.00%
2 YEAR CAGR
2.93%
5 YEAR CAGR
5.24%
10 YEAR CAGR